EUVIMEDEUVIMED entdecken
Crossref

Molecular diagnosis of cystic fibrosis by RNA obtained from nasal epithelial cells

Carmen Prior-de Castro, Miguel Ángel Martínez Gallego, Clara Gómez-González, Rubén de Sancho Martín, Carlos Rodríguez-Antolín, Carmen Rodríguez-Jiménez, Ángela Del Pozo Mate, Ester Zamarrón de Lucas, Marta Ruiz de Valbuena Maiz, Cristina de Manuel Gómez, Sergio Alcolea Batres, María Concepción Prados Sánchez und 1 weitere

Journal of Cystic Fibrosis · 2024

DOI: 10.1016/j.jcf.2023.12.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2024. Verfasst von Carmen Prior-de Castro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics-INGEMM, La Paz University Hospital, Servicio de Genética Bloque Quirúrgico, Planta -2, Paseo de la Castellana, Madri…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Nasal Mucosa. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The diagnosis of cystic fibrosis (CF) is established when characteristic clinical signs are coupled with biallelic CFTR pathogenic variants. No previously reported non-canonical splice site variants have to be considered as variants of uncertain significance unless their effect on splicing has been validated. METHODS: Two variants identified by next-generation sequencing were evaluated. We assayed their effects on splicing employing RNA analysis and real-time expression quantification from RNA obtained from the nasal epithelial cells of a patient with clinically suspected CF and of two patients with milder phenotypes (CFTR-related disorders). RESULTS: The variant c.164+2dup causes skipping of exon 2 (p.(Ser18_Glu54del)) and exon 2 plus 3 (p.(Ser18Argfs*16)) in CFTR mRNA. Exon 2 expression in the patient heterozygous for c.164+2dup was decreased to 7 % of the exon 2 expression in the controls. The synonymous variant c.1584G>A causes a partial skipping of exon 11. The exon 11 expression in the two patients heterozygous for this variant was 22 % and 42 % of that of the controls, respectively. CONCLUSION: We conclude that variant c.164+2dup affects mRNA processing and can be considered a CF-causing variant. The results of the functional assay also showed that the p.(Glu528=) variant, usually categorized as a neutral variant based on epidemiological data, partially affects mRNA processing in our patients. This finding would allow us to reclassify the variant as a CFTR-related variant with incomplete penetrance. RNA obtained from nasal epithelial cells is an easy and accurate tool for CFTR functional studies in patients with unclassified splice variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorNasal MucosaHumansMaleFemaleEpithelial CellsExonsRNA, MessengerRNA SplicingMutation

Stichwörter der Autor:innen

CF-causing variantCFTRCFTR-related variantNasal epithelial cellsRNA analysisSplicing

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorRNA, Messenger

Autor:innen und Institutionen

  • Department of Molecular Genetics-INGEMM, La Paz University Hospital, Servicio de Genética Bloque Quirúrgico, Planta -2, Paseo de la Castellana, Madrid 261 28046, Spain. Electronic address: carmen.prior@salud.madrid.org.
  • Department of Molecular Genetics-INGEMM, La Paz University Hospital, Servicio de Genética Bloque Quirúrgico, Planta -2, Paseo de la Castellana, Madrid 261 28046, Spain.
  • Biomarkers and Experimental Therapeutics in Cancer, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain.
  • Department of Next-Generation Sequencing-INGEMM, La Paz University Hospital, Madrid, Spain.
  • Department of Bioinformatics-INGEMM, La Paz University Hospital, Madrid, Spain.
  • Department of Pulmonology, La Paz University Hospital, Madrid, Spain.

Zitieren

APA

Prior-de Castro, C., Martínez Gallego, M. Á., Gómez-González, C., de Sancho Martín, R., Rodríguez-Antolín, C., Rodríguez-Jiménez, C., Del Pozo Mate, Á., Zamarrón de Lucas, E., Ruiz de Valbuena Maiz, M., de Manuel Gómez, C., Alcolea Batres, S., Prados Sánchez, M. C., & J Torres, R. (2024). Molecular diagnosis of cystic fibrosis by RNA obtained from nasal epithelial cells. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.12.007

Vancouver

Prior-de Castro C, Martínez Gallego MÁ, Gómez-González C, de Sancho Martín R, Rodríguez-Antolín C, Rodríguez-Jiménez C, et al. Molecular diagnosis of cystic fibrosis by RNA obtained from nasal epithelial cells. Journal of Cystic Fibrosis. 2024. doi:10.1016/j.jcf.2023.12.007

BibTeX
@article{PriordeCastro2024,
  author = {Prior-de Castro, Carmen and Martínez Gallego, Miguel Ángel and Gómez-González, Clara and de Sancho Martín, Rubén and Rodríguez-Antolín, Carlos and Rodríguez-Jiménez, Carmen and Del Pozo Mate, Ángela and Zamarrón de Lucas, Ester and Ruiz de Valbuena Maiz, Marta and de Manuel Gómez, Cristina and Alcolea Batres, Sergio and Prados Sánchez, María Concepción and J Torres, Rosa},
  title = {Molecular diagnosis of cystic fibrosis by RNA obtained from nasal epithelial cells},
  journal = {Journal of Cystic Fibrosis},
  year = {2024},
  doi = {10.1016/j.jcf.2023.12.007}
}
Kostenlos starten →